Biologics Research Review, Issue 82 – Dermatology focus
In this issue:
Comparative efficacy of biologics for psoriasis with nail involvement
Bimekizumab in psoriasis
Dupilumab in moderate-to-severe atopic dermatitis
Dupilumab and risk of cutaneous T cell lymphoma
Dupilumab for atopic dermatitis in patients with malignancy and other comorbidities
Omalizumab for chronic urticaria during pregnancy
Small-molecule inhibitors and biologics for palmoplantar psoriasis and pustulosis
Adalimumab + clindamycin + rifampicin in hidradenitis suppurativa
Live attenuated vaccine administration in dupilumab-treated children
Predictive factors of dupilumab response in moderate-to-severe atopic dermatitis
Expert contributor
Associate Professor Annika Smith
Dr Annika Smith is a Fellow of the Australasian College of Dermatologists and Consultant Dermatologist in public and private settings in Sydney. Annika undertook training at the prestigious St John’s Institute of Dermatology London, followed by further sub-specialty training in New York. Annika has a special interest in complex medical dermatology, including clinical and research […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.